Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids: Melbourne, Australia Saturday, No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback